{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:09:03Z","timestamp":1794330543841,"version":"4.9.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005485","name":"American College of Cardiology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005485","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ahj.2025.07.015","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T06:34:23Z","timestamp":1753338863000},"page":"26-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Relationship between industry payments to physicians and prescription patterns for PCSK9is, ARNis and DOACs: A report from the NCDR PINNACLE registry"],"prefix":"10.1016","volume":"291","author":[{"given":"Amarnath R.","family":"Annapureddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Murugiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl E.","family":"Minges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowtham R.","family":"Grandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Rodwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanket S.","family":"Dhruva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saket","family":"Girotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias J.","family":"Dayoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeptha P.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9732-4903","authenticated-orcid":false,"given":"Nihar R.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2025.07.015_bib0001","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1056\/NEJMp1303523","article-title":"The Sunshine Act\u2013effects on physicians","volume":"368","author":"Agrawal","year":"2013","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ahj.2025.07.015_bib0002","unstructured":"Federal Register. Medicare, Medicaid, children\u2019s health insurance programs; transparency reports and reporting of physician ownership or investment interests: a rule by the Centers for Medicare & Medicaid Services. https:\/\/www.federalregister.gov\/documents\/2013\/02\/08\/2013-02572\/medicare-medicaid-childrens-health-insurance-programs-transparency-reports-and-reporting-of. Accessed April 2023."},{"key":"10.1016\/j.ahj.2025.07.015_bib0003","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1001\/jama.2017.3091","article-title":"Types and distribution of payments from industry to physicians in 2015","volume":"317","author":"Tringale","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2025.07.015_bib0004","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s002280050121","article-title":"Auditing GPs' prescribing habits: cardiovascular prescribing frequently continues medication initiated by specialists","volume":"50","author":"de Vries","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2025.07.015_bib0005","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jama.2024.1989","article-title":"Industry payments to US physicians by specialty and product type","volume":"331","author":"Sayed","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2025.07.015_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.007521","article-title":"Association between industry marketing payments and prescriptions for PCSK9 (Proprotein Convertase Subtilisin\/Kexin Type 9) inhibitors in the United States","volume":"14","author":"Inoue","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2025.07.015_bib0007","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1001\/jamainternmed.2016.2765","article-title":"Pharmaceutical industry-sponsored meals and physician prescribing patterns for Medicare beneficiaries","volume":"176","author":"DeJong","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ahj.2025.07.015_bib0008","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/jamainternmed.2016.1709","article-title":"Association of Industry payments to physicians with the prescribing of brand-name statins in Massachusetts","volume":"176","author":"Yeh","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ahj.2025.07.015_bib0009","first-page":"i4189","article-title":"Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study","volume":"354","author":"Fleischman","year":"2016","journal-title":"BMJ (Clin Res Ed)"},{"key":"10.1016\/j.ahj.2025.07.015_bib0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jacc.2019.11.011","article-title":"Trends in U.S. ambulatory cardiovascular care 2013 to 2017: JACC review topic of the week","volume":"75","author":"Maddox","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2025.07.015_bib0011","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/clc.23142","article-title":"Anticoagulation in patients with atrial fibrillation and heart failure: insights from the NCDR PINNACLE-AF registry","volume":"42","author":"Contreras","year":"2019","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ahj.2025.07.015_bib0012","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ahj.2018.03.003","article-title":"Predictors of oral anticoagulant non-prescription in patients with atrial fibrillation and elevated stroke risk","volume":"200","author":"Lubitz","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2025.07.015_bib0013","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jacc.2010.03.043","article-title":"Cardiac performance measure compliance in outpatients: the American College of Cardiology and National Cardiovascular Data Registry's PINNACLE (Practice Innovation And Clinical Excellence) program","volume":"56","author":"Chan","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2025.07.015_bib0014","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMp1509103","article-title":"The physician Payments Sunshine Act\u2013two years of the Open Payments program","volume":"374","author":"Agrawal","year":"2016","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ahj.2025.07.015_bib0015","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005016","article-title":"Industry payments to cardiologists","volume":"11","author":"Annapureddy","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2025.07.015_bib0016","unstructured":"Natures of Payment. https:\/\/www.cms.gov\/OpenPayments\/About\/Natures-of-Payment."},{"key":"10.1016\/j.ahj.2025.07.015_bib0017","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/clc.23376","article-title":"Switching warfarin to direct oral anticoagulants in atrial fibrillation: insights from the NCDR PINNACLE registry","volume":"43","author":"Sciria","year":"2020","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ahj.2025.07.015_bib0018","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.jacc.2017.03.540","article-title":"Influence of direct oral anticoagulants on rates of oral anticoagulation for atrial fibrillation","volume":"69","author":"Marzec","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2025.07.015_bib0019","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1001\/jama.2020.17436","article-title":"Association between industry payments to physicians and device selection in ICD implantation","volume":"324","author":"Annapureddy","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2025.07.015_bib0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2018.8775","article-title":"Distribution of industry payments among medical directors of catheterization and electrophysiology laboratories from the top 100 US hospitals","author":"Annapureddy","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ahj.2025.07.015_bib0021","article-title":"Are financial payments from the pharmaceutical industry associated with physician prescribing?: a systematic review","author":"Mitchell","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2025.07.015_bib0022","doi-asserted-by":"crossref","unstructured":"Alpert A., Lakdawalla, D. and Sood, N. Prescription drug advertising and drug utilization: the role of Medicare Part D. http:\/\/www.nber.org\/papers\/w21714. Accessed No. 21714. Accessed April 10, 2023.","DOI":"10.1016\/j.jpubeco.2023.104860"},{"key":"10.1016\/j.ahj.2025.07.015_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1257\/pol.20200044","article-title":"Drug diffusion through peer networks: the influence of industry payments","volume":"14","author":"Agha","year":"2022","journal-title":"Am Econ J Econ Policy"},{"key":"10.1016\/j.ahj.2025.07.015_bib0024","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2025.07.015_bib0025","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","volume":"77","author":"Maddox","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2025.07.015_bib0026","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2025.07.015_bib0027","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2025.07.015_bib0028","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004302","article-title":"Adoption of Sacubitril\/Valsartan for the management of patients with heart failure","volume":"11","author":"Sangaralingham","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2025.07.015_bib0029","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.37288","article-title":"Clinician trends in prescribing direct oral anticoagulants for US Medicare beneficiaries","volume":"4","author":"Wheelock","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ahj.2025.07.015_bib0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019331","article-title":"Adoption of PCSK9 inhibitors among patients with atherosclerotic disease","volume":"10","author":"Dayoub","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2025.07.015_bib0031","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026723","article-title":"Trends in oral anticoagulant use among 436\u2009864 patients with atrial fibrillation in community practice, 2011 to 2020","volume":"11","author":"Navar","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2025.07.015_bib0032","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.hjdsi.2017.09.004","article-title":"Patterns and predictors of physician adoption of new cardiovascular drugs","volume":"6","author":"Anderson","year":"2018","journal-title":"Healthc (Amst)"},{"key":"10.1016\/j.ahj.2025.07.015_bib0033","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1472-6963-12-56","article-title":"Adoption of new drugs by physicians: a survival analysis","volume":"12","author":"Garj\u00f3n","year":"2012","journal-title":"BMC Health Serv Res"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870325002248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870325002248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:23:53Z","timestamp":1779769433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870325002248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":33,"alternative-id":["S0002870325002248"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2025.07.015","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between industry payments to physicians and prescription patterns for PCSK9is, ARNis and DOACs: A report from the NCDR PINNACLE registry","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2025.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}